Delayed
Bombay S.E.
05:05:06 2024-04-29 am EDT
|
5-day change
|
1st Jan Change
|
1,247
INR
|
+4.27%
|
|
+12.51%
|
+5.82%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
14,177
|
18,102
|
16,309
|
33,127
|
73,379
|
41,041
|
Enterprise Value (EV)
1 |
17,323
|
22,850
|
21,213
|
38,401
|
82,311
|
51,680
|
P/E ratio
|
27.6
x
|
19.2
x
|
9.25
x
|
28.3
x
|
75.4
x
|
185
x
|
Yield
|
0.4%
|
0.54%
|
0.36%
|
0.24%
|
0.11%
|
-
|
Capitalization / Revenue
|
1.38
x
|
1.35
x
|
1
x
|
2.6
x
|
5.23
x
|
2.55
x
|
EV / Revenue
|
1.69
x
|
1.7
x
|
1.3
x
|
3.01
x
|
5.86
x
|
3.21
x
|
EV / EBITDA
|
13.3
x
|
10.4
x
|
7.98
x
|
18.8
x
|
43.3
x
|
28.9
x
|
EV / FCF
|
-169
x
|
-13
x
|
-41.9
x
|
-33.4
x
|
-23.2
x
|
-33.8
x
|
FCF Yield
|
-0.59%
|
-7.69%
|
-2.39%
|
-3%
|
-4.31%
|
-2.96%
|
Price to Book
|
2.88
x
|
3.14
x
|
2.2
x
|
4.58
x
|
9.03
x
|
4.95
x
|
Nbr of stocks (in thousands)
|
37,610
|
39,063
|
39,063
|
39,063
|
39,063
|
39,063
|
Reference price
2 |
377.0
|
463.4
|
417.5
|
848.0
|
1,878
|
1,051
|
Announcement Date
|
7/17/18
|
7/12/19
|
10/9/20
|
8/3/21
|
8/29/22
|
7/17/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
10,243
|
13,410
|
16,306
|
12,766
|
14,037
|
16,078
|
EBITDA
1 |
1,300
|
2,199
|
2,658
|
2,044
|
1,903
|
1,787
|
EBIT
1 |
869.4
|
1,732
|
2,056
|
1,366
|
1,192
|
780.8
|
Operating Margin
|
8.49%
|
12.91%
|
12.61%
|
10.7%
|
8.49%
|
4.86%
|
Earnings before Tax (EBT)
1 |
789.6
|
1,516
|
2,313
|
1,582
|
1,328
|
310.4
|
Net income
1 |
533.4
|
942.4
|
1,763
|
1,169
|
973.8
|
222.1
|
Net margin
|
5.21%
|
7.03%
|
10.81%
|
9.16%
|
6.94%
|
1.38%
|
EPS
2 |
13.65
|
24.13
|
45.14
|
29.93
|
24.93
|
5.687
|
Free Cash Flow
1 |
-102.2
|
-1,757
|
-506.4
|
-1,151
|
-3,548
|
-1,531
|
FCF margin
|
-1%
|
-13.1%
|
-3.11%
|
-9.02%
|
-25.28%
|
-9.52%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
1.500
|
2.500
|
1.500
|
2.000
|
2.000
|
-
|
Announcement Date
|
7/17/18
|
7/12/19
|
10/9/20
|
8/3/21
|
8/29/22
|
7/17/23
|
Fiscal Period: March |
2022 Q1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
---|
Net sales
1 |
-
|
-
|
3,769
|
3,888
|
EBITDA
1 |
-
|
-
|
475.8
|
585.7
|
EBIT
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
406.7
|
-
|
Net income
|
1,169
|
249.5
|
299.1
|
-
|
Net margin
|
-
|
-
|
7.94%
|
-
|
EPS
2 |
-
|
-
|
-
|
5.740
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
8/3/21
|
1/27/22
|
5/5/22
|
8/10/22
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
3,146
|
4,748
|
4,904
|
5,274
|
8,932
|
10,639
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.419
x
|
2.159
x
|
1.845
x
|
2.58
x
|
4.693
x
|
5.955
x
|
Free Cash Flow
1 |
-102
|
-1,757
|
-506
|
-1,151
|
-3,548
|
-1,531
|
ROE (net income / shareholders' equity)
|
11.4%
|
17.7%
|
26.8%
|
17.5%
|
12.6%
|
2.57%
|
ROA (Net income/ Total Assets)
|
5.46%
|
8.73%
|
8.48%
|
5.84%
|
4.01%
|
2.14%
|
Assets
1 |
9,777
|
10,791
|
20,786
|
20,021
|
24,292
|
10,396
|
Book Value Per Share
2 |
131.0
|
147.0
|
190.0
|
185.0
|
208.0
|
212.0
|
Cash Flow per Share
2 |
3.220
|
4.160
|
21.70
|
3.960
|
8.320
|
5.230
|
Capex
1 |
934
|
1,691
|
2,107
|
2,428
|
3,086
|
1,397
|
Capex / Sales
|
9.12%
|
12.61%
|
12.92%
|
19.02%
|
21.99%
|
8.69%
|
Announcement Date
|
7/17/18
|
7/12/19
|
10/9/20
|
8/3/21
|
8/29/22
|
7/17/23
|
|
1st Jan change
|
Capi.
|
---|
| +5.82% | 560M | | +11.47% | 63.22B | | -2.56% | 46.34B | | +14.04% | 39.97B | | +17.83% | 25.46B | | +7.64% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +1.52% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|